Exchange: NASDAQ·Updated 07:30 PM EDT

MSLE Satellos Bioscience Inc

$9.11
$0.11
(1.21%)
Today
Closed $8.97
$0.14
(1.56%)
After Hours
Mkt Cap$190.31M
Vol25,590.00

About MSLE

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.
57

Bullish Sentiment

How do you feel about MSLE?

Advertisement|Remove ads.